GSD delivers cost-efficient, inclusive and scalable research

Delivering Cost-Efficient, Inclusive & Scalable Research

Our team has over a decade of experience developing industry-changing approaches in clinical research.

GSD has been conducting academic and clinical research studies since 2014 that focus on efficient and effective data aggregation and application
in collaboration with Scripps Research, Johnson & Johnson and Aetna launched the ground-breaking pragmatic trial with first nationwide direct-to-participant enrollment

Sync for Science program enabled the first patient-mediated EHR sharing for clinical research in partnership with Harvard and GSD Health Inc

All of us Research program recieved a $200M grant from the NIH to lead the participant center for the largest, most diverse research cohort which enrolled over 800k participants, half from underrepresented communities

scripps digital trials center Scripps Digital Trials Center launched DTC to advance decentralized and remote digital trials, partnering with dozens of organizations across the globe


DETECT enrolled 40k people nationwide with wearable devices to develop the first AI/ML algorithms for COVID predication published in Nature Medicine. Partners include Johnson & Johnson, Rockefeller foundation and FitBit

PowerMom Nationwide launch of a Pregnancy Research Study collecting multi-modal data from pregnant women across the country with support from Microsoft, WebMD, Philips, BCBSA, March of Dimes, Walgreens, Google, and the McGovern Foundation

Industry-wide Presence - with active participation and partnership with organizations that are using advanced methodologies for real world data collection and improving diversity in clinical trials

GSD did a study of sleep in women over 55 years old in partnership with Scripps health to launch study with real-time return of health data examining the correlation between sleep and cognitive decline in women 55+

Multi-Modal metabolic health study call the PROGRESS study which was the most robust remote digital trial to date in metabolic health sponsored by Tempus and Dexcom.

GSD health has over a decade of experience in clinical and academic research studies focused on innovation and diversity in women's health

With Scripps Research, Johnson & Johnson, and Aetna, launched the ground-breaking pragmatic trial with first nationwide direct-to-participant enrollment

Helped develop the program that enabled the first patient-mediated EHR sharing for clinic research in partnership with Harvard

Received a $200M grant from the NIH to lead the Participant Center for the largest, most diverse research cohort which enrolled over 800K participants, half from underrepresented communities

Scripps Digital Trials Center launched DTC to advance decentralized and remote digital trials, partnering with dozens of organizations across the globe

Co-authored the widely praised industry digital handbook on the use of wearables and sensors in clinical research, now a key resource within DiMe.

Enrolled 40,000 people nationwide with wearable devices to develop the first AI/ML algorithms for COVID predication published in Nature Medicine. Partners included Johnson & Johnson, Rockefeller Foundation and Fitbit and research was covered in the New York Times and The Economist

Nationwide launch of a Pregnancy Research Study collecting multi-modal data from pregnant women across the country with support from Microsoft, WebMD, Philips, BCBSA, March of Dimes, Walgreens, Google, and the McGovern Foundation

Industry-wide Presence

Active participation and partnership with organizations including DiMe, DTRA, CTTI, and HRfH to advance methodologies for real-world data collection and improving diversity in clinical trials 

Partnered with Scripps Health to launch study with real-time return of health data examining the correlation between sleep and cognitive decline in women 55+

Multi-modal Metabolic Health Study 

Conducted the PROGRESS Study—the most robust remote, digital trial to date in metabolic health, sponsored by Tempus and Dexcom. The study collected deep, real-world multimodal data, including remote biosample collection, and led to the development of predictive algorithms for improved risk profiling in pre-diabetics.

Our experience has shaped a new model for clinical research

One that is scalable, efficient, and inclusive. Today, we partner with pharma, medtech, and academic researchers to accelerate discovery in women’s health, delivering innovative, cost-effective solutions that drive real-world impact.

Advancing Health Research With Purpose Innovation Impact You

We believe that the future of health research is built together—with scientists, pharma leaders, clinicians, and technology pioneers driving impact at every step. Let’s collaborate to make research smarter, faster, and more inclusive for all generations.